Ken Griffin Neuroone Medical Technologies Corp Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 69,600 shares of NMTC stock, worth $42,456. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,600
Previous 40,800
70.59%
Holding current value
$42,456
Previous $33,000
78.79%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NMTC
# of Institutions
21Shares Held
1.93MCall Options Held
69.6KPut Options Held
2K-
Vanguard Group Inc Valley Forge, PA1.11MShares$677,5200.0% of portfolio
-
Geode Capital Management, LLC Boston, MA346KShares$211,0450.0% of portfolio
-
Goldman Sachs Group Inc New York, NY98.6KShares$60,1290.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.81KShares$49,4100.0% of portfolio
-
State Street Corp Boston, MA59.5KShares$36,2940.0% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $9.89M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...